CSL Ltd. (CSLLY)
58.53
-0.25
(-0.43%)
USD |
OTCM |
Jan 09, 16:00
CSL Market Cap: 56.68B for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 63.80M |
| Kazia Therapeutics Ltd. | 77.31M |
| Immutep Ltd. | 429.40M |
| Propanc Biopharma, Inc. | 6.177M |
| Mesoblast Ltd. | 2.682B |
Market Cap Related Metrics
| PS Ratio | 3.689 |
| PEG Ratio | 0.5692 |
| Price to Free Cash Flow | 22.20 |
| Price | 58.53 |
| Earnings Yield | 5.27% |
| PEGY Ratio | 0.5295 |
| Operating PE Ratio | 14.12 |
| Normalized PE Ratio | 18.94 |